Male/female adults
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Case group; The subjects who previously had at least two polyps removed, and who have been taking Lacticaseibacillus preparations for more than 20 years Control group; The subjects who previously had at least two polyps removed, and who have not been taking Lacticaseibacillus preparations and/or Yakult products
Exclusion criteria
Exclusion criteria: In the case of treating antibiotics within 4 weeks
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Analysis of host-derived cells affected by taking Lacticaseibacillus preparations in intestinal tissues | — |
Secondary
| Measure | Time frame |
|---|---|
| Analysis of host immune cells in periphery, intestinal microbiota affected by long-term ingestion of Lacticaseibacillus preparations. | — |
Countries
Japan
Contacts
Ishikawa Gastroenterology Clinic Gastroenterology